ask="N/A"
ask_size="N/A"
average_daily_volume="25394"
bid="N/A"
bid_size="N/A"
book_value="0.44"
change="+0.35"
change_from_200_day_moving_average="2.35"
change_from_50_day_moving_average="0.73"
change_from_52_week_high="-3.19"
change_From_52_week_low="4.60"
change_in_percent="+5.22%"
close="7.05"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.46"
ebitda="-11.23M"
eps_estimate_current_year="-0.42"
eps_estimate_next_quarter="-0.16"
eps_estimate_next_year="-0.49"
ex_dividend_date="N/A"
float_shares="3301000"
high="7.05"
high_52_weeks="10.24"
last_trade_date="12/30/2016"
last_trade_price="7.05"
last_trade_size="1500"
last_trade_time="4:00pm"
low="6.80"
low_52_weeks="2.45"
market_capitalization="202.40M"
moving_average_200_day="4.70"
moving_average_50_day="6.32"
name="OncoCyte Corporation Common Sto"
notes="N/A"
one_year_target_price="9.67"
open="6.84"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+50.08%"
percent_change_from_50_day_moving_average="+11.52%"
percent_change_from_52_week_high="-31.15%"
percent_change_from_52_week_low="+187.76%"
previous_close="6.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="15.16"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28709000"
short_ratio="2.08"
stock_exchange="ASE"
symbol="OCX"
volume="16471"
weeks_range_52="2.45 - 10.24"
